New long-term clinical data presented by Eisai add to growing evidence that LEQEMBI (lecanemab) may continue to slow disease progression in certain adults with early Alzheimer’s disease when treatment is maintained over several years. …
New long-term data suggest sustained benefit of Eisai therapy in early Alzheimer’s Disease
January 30, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
The 'Dispatched' Week in Review' Podcast - 15 May
May 15, 2026 - - Podcast -
New Zealand still falling behind on access to modern medicines
May 15, 2026 - - Latest News -
AusBiotech welcomes Budget's creation of new National Resilience and Science Council
May 15, 2026 - - Latest News -
Minister fired the starting gun in March, he flung the door open in Budget week
May 14, 2026 - - Latest News -
There are a number of reasons to criticise the minister on the PBS, but he is right to be annoyed about this
May 14, 2026 - - Latest News -
Long-term study finds continuing Mounjaro helps maintain weight loss
May 14, 2026 - - Latest News -
Frustrated minister encourages an early negotiation of new agreements
May 14, 2026 - - Latest News